AT342199B - Verfahren zur herstellung von neuen verbindungen - Google Patents

Verfahren zur herstellung von neuen verbindungen

Info

Publication number
AT342199B
AT342199B AT215576A AT215576A AT342199B AT 342199 B AT342199 B AT 342199B AT 215576 A AT215576 A AT 215576A AT 215576 A AT215576 A AT 215576A AT 342199 B AT342199 B AT 342199B
Authority
AT
Austria
Prior art keywords
producing new
new connections
connections
producing
new
Prior art date
Application number
AT215576A
Other languages
German (de)
English (en)
Other versions
ATA215576A (de
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB15209/75A external-priority patent/GB1545467A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of ATA215576A publication Critical patent/ATA215576A/de
Application granted granted Critical
Publication of AT342199B publication Critical patent/AT342199B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02Preparation
    • C07D503/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT215576A 1975-04-14 1976-03-24 Verfahren zur herstellung von neuen verbindungen AT342199B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB15209/75A GB1545467A (en) 1975-04-14 1975-04-14 Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof
GB3967175 1975-09-27

Publications (2)

Publication Number Publication Date
ATA215576A ATA215576A (de) 1977-07-15
AT342199B true AT342199B (de) 1978-03-28

Family

ID=26251136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT215576A AT342199B (de) 1975-04-14 1976-03-24 Verfahren zur herstellung von neuen verbindungen

Country Status (22)

Country Link
JP (1) JPS51127093A (sv)
AR (1) AR208773A1 (sv)
AT (1) AT342199B (sv)
AU (1) AU497577B2 (sv)
CA (1) CA1074802A (sv)
CH (1) CH602742A5 (sv)
DE (1) DE2616088A1 (sv)
DK (1) DK144066C (sv)
ES (1) ES446468A1 (sv)
FI (1) FI760946A (sv)
FR (1) FR2336130A1 (sv)
GR (1) GR58256B (sv)
HU (1) HU175444B (sv)
IE (1) IE42666B1 (sv)
IL (1) IL49279A (sv)
LU (1) LU74749A1 (sv)
MX (1) MX3453E (sv)
NL (1) NL7603840A (sv)
NO (1) NO761241L (sv)
PT (1) PT64897B (sv)
SE (1) SE427037B (sv)
YU (1) YU69476A (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (fr) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Derives de la clavuline et leur procede de preparation
AT363181B (de) * 1976-10-25 1981-07-10 Glaxo Lab Ltd Verfahren zur herstellung von neuen clavulansaeurederivaten
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition

Also Published As

Publication number Publication date
ES446468A1 (es) 1977-11-01
GR58256B (en) 1977-09-15
HU175444B (hu) 1980-08-28
DK156576A (da) 1976-10-15
YU69476A (en) 1982-05-31
JPS51127093A (en) 1976-11-05
MX3453E (es) 1980-12-03
ATA215576A (de) 1977-07-15
NO761241L (sv) 1976-10-15
IE42666B1 (en) 1980-09-24
FI760946A (sv) 1976-10-15
SE7604287L (sv) 1976-10-15
CH602742A5 (sv) 1978-07-31
FR2336130A1 (fr) 1977-07-22
PT64897B (en) 1977-08-18
AR208773A1 (es) 1977-02-28
AU1302076A (en) 1977-10-20
IL49279A0 (en) 1976-06-30
DE2616088A1 (de) 1976-10-28
DK144066C (da) 1982-05-10
AU497577B2 (en) 1978-12-21
LU74749A1 (sv) 1976-11-11
DK144066B (da) 1981-11-30
IE42666L (en) 1976-10-14
PT64897A (en) 1976-04-01
SE427037B (sv) 1983-02-28
CA1074802A (en) 1980-04-01
NL7603840A (nl) 1976-10-18
IL49279A (en) 1979-05-31
FR2336130B1 (sv) 1979-06-22

Similar Documents

Publication Publication Date Title
AT337363B (de) Verfahren zur herstellung von neuen daunomycinanaloga
AT344894B (de) Verfahren zur herstellung von neuen cephemverbindungen
AT334394B (de) Verfahren zur herstellung von neuen amidin-metall-komplexen
AT342769B (de) Verfahren zur herstellung von neuen 1-oxacephemen
AT350064B (de) Verfahren zur herstellung von neuen thienothiazinderivaten
ATA247775A (de) Verfahren zur herstellung von neuen acylureidocephalosporinen
ATA412175A (de) Verfahren zur herstellung von neuen biguaniden
AT338773B (de) Verfahren zur herstellung von neuen aminotetralolverbindungen
ATA3476A (de) Verfahren zur herstellung von neuen verbindungen
AT337672B (de) Verfahren zur herstellung von neuen abietamidderivaten
AT337897B (de) Verfahren zur herstellung von neuen acylderivaten
AT354650B (de) Verfahren zur herstellung von neuen bicyclo- heptenderivaten
AT339334B (de) Verfahren zur herstellung von neuen organosiliciumverbindungen
AT342199B (de) Verfahren zur herstellung von neuen verbindungen
AT329182B (de) Verfahren zur herstellung von neuen cephalosporinsulfonatestern
AT353957B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT339333B (de) Verfahren zur herstellung von neuen organosiliciumverbindungen
AT349630B (de) Verfahren zur herstellung von neuen antibiotika
ATA783575A (de) Verfahren zur herstellung von neuen nitrofurylverbindungen
AT330774B (de) Verfahren zur herstellung von neuen bicyclischen verbindungen
ATA504978A (de) Verfahren zur herstellung von neuen thienothiazinderivaten
AT331423B (de) Verfahren zur herstellung von neuen desglucohellebrin-derivaten
ATA649277A (de) Verfahren zur herstellung von neuen benzhydrylsulfinylalkylamidinen
AT350724B (de) Verfahren zur herstellung von neuen cephem- verbindungen
ATA677077A (de) Verfahren zur herstellung von neuen cephem-ver- bindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties